These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 9428670)
1. Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells. Hichami A; Duroudier V; Leblais V; Vernhet L; Le Goffic F; Ninio E; Legrand A Eur J Biochem; 1997 Dec; 250(2):242-8. PubMed ID: 9428670 [TBL] [Abstract][Full Text] [Related]
2. Phorbol diester enhances calcium ionophore A23187-induced [3H]acetate incorporation into platelet-activating factor in murine macrophages: predominant incorporation into 1-O-acyl-2-acetyl-sn-glycero-3-phosphocholine. Wey HE J Cell Biochem; 1989 Mar; 39(3):305-13. PubMed ID: 2496135 [TBL] [Abstract][Full Text] [Related]
3. Modulation of PAF production by incorporation of arachidonic acid and eicosapentaenoic acid in phospholipids of human leukemic monocyte-like cells THP-1. Martin-Chouly CA; Menier V; Hichami A; Youmine H; Noel F; Pedrono F; Legrand AB Prostaglandins Other Lipid Mediat; 2000 Mar; 60(4-6):127-35. PubMed ID: 10751643 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells. Chepenik KP; Wykle RL Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622 [TBL] [Abstract][Full Text] [Related]
5. Biosynthesis and metabolism of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine in rat glomerular mesangial cells. Lianos EA; Zanglis A J Biol Chem; 1987 Jul; 262(19):8990-3. PubMed ID: 3110152 [TBL] [Abstract][Full Text] [Related]
6. Metabolic fate of platelet-activating factor (PAF, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) in FRTL5 cells. Botitsi E; Mavri-Vavayanni M; Siafaka-Kapadai A J Lipid Res; 1998 Jun; 39(6):1295-304. PubMed ID: 9643362 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells. Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974 [TBL] [Abstract][Full Text] [Related]
11. Two different sites of action for platelet activating factor and 1-O-alkyl-2-O-methyl-sn-glycero-3-phosphocholine on platelets and leukemic cells. Salari H; Dryden P; Howard S; Bittman R Biochem Cell Biol; 1992 Feb; 70(2):129-35. PubMed ID: 1324692 [TBL] [Abstract][Full Text] [Related]
12. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. Triggiani M; Connell TR; Chilton FH J Immunol; 1990 Oct; 145(7):2241-8. PubMed ID: 2118931 [TBL] [Abstract][Full Text] [Related]
13. Conversion of alkylacetylglycerol to platelet-activating factor in HL-60 cells and subcellular localization of the mediator. Vallari DS; Record M; Snyder F Arch Biochem Biophys; 1990 Feb; 276(2):538-45. PubMed ID: 2154953 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids. Sturk A; Schaap MC; Prins A; ten Cate JW; van den Bosch H Biochim Biophys Acta; 1989 Dec; 993(2-3):148-56. PubMed ID: 2512985 [TBL] [Abstract][Full Text] [Related]
15. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
16. Lipoxygenase products of arachidonic acid modulate biosynthesis of platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) by human neutrophils via phospholipase A2. Billah MM; Bryant RW; Siegel MI J Biol Chem; 1985 Jun; 260(11):6899-906. PubMed ID: 3922982 [TBL] [Abstract][Full Text] [Related]
17. Evidence that hydrolysis of ethanolamine plasmalogens triggers synthesis of platelet-activating factor via a transacylation reaction. Nieto ML; Venable ME; Bauldry SA; Greene DG; Kennedy M; Bass DA; Wykle RL J Biol Chem; 1991 Oct; 266(28):18699-706. PubMed ID: 1917994 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and lyso-PAF (1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine) by cultured rat Kupffer cells. Chao W; Siafaka-Kapadai A; Hanahan DJ; Olson MS Biochem J; 1989 Jul; 261(1):77-81. PubMed ID: 2775221 [TBL] [Abstract][Full Text] [Related]
19. Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes. Winkler JD; Bolognese BJ; Roshak AK; Sung CM; Marshall LA Biochim Biophys Acta; 1997 Jun; 1346(2):173-84. PubMed ID: 9219900 [TBL] [Abstract][Full Text] [Related]
20. Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells. Triggiani M; Schleimer RP; Warner JA; Chilton FH J Immunol; 1991 Jul; 147(2):660-6. PubMed ID: 2071900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]